Effect of Nutraceutical Formulation Ovajal on DHT and Fructose-induced Polycystic Ovary Syndrome in a Rodent Model

Authors

  • G. SANTHANA KUMAR Department of Pharmacology, School of Pharmacy, R.K. University - Rajkot - 360020, Gujarat, India
  • Pravin R. Tirgar Department of Pharmacology, School of Pharmacy, R.K. University - Rajkot - 360020, Gujarat, India
  • Punit R. Rachh AyuNutra Pharmaceuticals, Rajkot -360005, Gujarat, India

Abstract

Polycystic ovary syndrome is a most common female reproductive disorder, involving endocrine and metabolic disorders with unclear etiology. It may clinically be manifested in young women of reproductive age as oligo-ovulation, abnormal levels of reproductive hormones, clinical hyperandrogenism, hirsutism, male pattern baldness, acne, acanthosis nigricans, and polycystic ovaries, additionally having a long prodroma with detectable abnormalities that present as the metabolic syndrome like Insulin resistance, hyperinsulinemia, obesity, and dyslipidemia. Current treatment options are unable to manage PCOS and suffer from unwanted effects. The present study aimed to investigate the effect of nutraceutical formulation ovajal on dihydrotestosterone (DHT)-fructose-induced polycystic ovary syndrome (PCOS) in Sprague Dawley (S.D.) female rats. Prepubertal rats in the experimental group (except control) received coadministration of DHT (s.c.) and fructose(p.o.). Along with DHT+F other groups were treated with OV100 & OV200, clomiphene, and metformin, at a dose of 100 mg/kg p.o., 200 mg/kg p.o., 100 mg/kg p.o., & 200 mg/kg p.o., respectively for 90 days. Estrus cyclicity, OGTT, luteinizing hormone, follicle-stimulating hormone, insulin, testosterone, and estradiol serum levels were assessed. Ovary, uterus, abdominal fat, and subcutaneous fat were collected, weighed and an ovary histomorphology examination was done. Results showed that OV100 and OV200 reversed the DHT-fructose induced changes by significantly (p < 0.05) increasing serum FSH level, estradiol level and decreasing their body weight, ovary weight, uterine weight, serum luteinizing hormone level, testosterone level, oral glucose tolerance, irregular estrous cyclicity and no. of cystic follicles. However, the OV200 notably ameliorated the abnormalities of experimental PCOS. Our study findings demonstrate that ovajal formulation exerted preventive benefits in an experimental model of PCOS. Hence can be suggested in the management of PCOS.

Keywords:

Ovajal, nutraceutical formulation, Fructose, DHT, Polycystic ovarian syndrome, metformin, clomiphene citrate

DOI

https://doi.org/10.25004/IJPSDR.2022.140216

References

Escobar-Morreale HF. Polycystic ovary syndrome: definition, aet iolog y, diag nosis, and t reatment . Nat Rev Endocrinol. 2018;14(5):270–284.

Jeshica Bulsara, Priyanshi P, Arun S, Sanjeev A. A review: Brief insight into polycystic ovarian syndrome. Endocrine and Metabolic Science.2021;1(3):100085-100087.

Asha KV, Veena GT. Polycystic Ovarian Syndrome – An Overview. Int. J. Nur. Edu. and Research. 2019; 7(4): 601-604.

Baldani DP. Polycystic ovary syndrome: important under recognised cardiometabolic risk factor in reproductive-age women.Int J Endocrinol. 2015; 23(1):34-38 .

Doi SA. Neuroendocrine dysfunction in PCOS: a critique of recent reviews. Clin Med Res. 2008; 6(2): 47-53.

Takayama K, Fukaya T, Sasano H, Funayama Y, Suzuki T, Takaya R, et al. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Hum Reprod. 1996; 1197: 1387-92.

Yaba A, Demir N. The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS). J Ovarian Res. 2012; 5(1): 38-40.

Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012; 33(6): 981-1030.

Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005; 352(12): 1223-36.

Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43(8): 1066-84.

Muscogiuri G, Policola C, Prioletta A, Sorice G, Mezza T, Lassandro A. Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clinical. Nutrition. 2012; 31(1): 476-80.

Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical Endocrinolgy. 2012; 77(3): 343-50.

Jakimiuk AJ, Szamatowicz J. The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders. Ginekol Pol. 2014; 85(1):54-57.

Günalan E, Yaba A, Yılmaz B. The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review. J Turkish Ger Gynecol Assoc. 2018;19(4):220-224.

Arentz S, Abbott JA, Smith CA, Bensoussan A. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement Altern Med. 2014;14(1):1–19.

Choi HD, Kim JH, Chang MJ, Kyu‐Youn Y, Shin WG. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phyther Res. 2011;25(12):1813–1818.

Advani K, Batra M, Tajpuriya S, Gupta R, Saraswat A, Nagar HD, et.al. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study. J Obstet Gynaecol (Lahore). 2020;40(1):96–101.

Fouany MR, Sharara FI. Is there a role for DHEA supplementation in women with diminished ovarian reserve? J Assist Reprod Genet. 2013;30(9):1239–1244.

Atef MM, Abd-Ellatif RN, Emam MN, Amer AI, Hafez YM. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS). Arch Biochem Biophys. 2019; 671:245–254.

Razavi M, Jamilian M, Kashan ZF, Heidar Z, Mohseni M, Ghandi Y, et al. Selenium supplementation and the effects on reproductive outcomes, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res. 2016;48(3):185–190.

Yan X, Dai X, Wang J, Zhao N, Cui Y, Liu J. Prenatal androgen excess programs metabolic derangements in pubertal female rats. J Endocrinol. 2013;217(1):119–29. Schlede E, Genschow E, Spielmann H, Stropp G, Kayser D. Oral acute toxic class method: a successful alternative to the oral LD50 test. Regul. Toxicol. Pharmacol. 2005;42(1):15–23.

Maliqueo M, Benrick A, Stener-Victorin E. Rodent models of polycystic ovary syndrome: phenotypic presentation, pathophysiology, and the effects of different interventions. In: Seminars in reproductive medicine. Thieme Medical Publishers. 2014; 32(3): 183–193.

Feng Y, Johansson J, Shao R, Mannerås L, Fernandez-Rodriguez J, Billig H, et al. Hypothalamic neuroendocrine functions in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture. PLoS One. 2009;4(8): e6638.

A.P. Arikawe, B.O. Iranloye, A.O. Ogunsola, A.O. Daramola. Chronic fructose consumption as a model of polycystic ovary syndrome in pregnant female Sprague-Dawley rats, African J. Biomed. Res. 2012;15(1):1-17.

D. Shi, D.F. Vine. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenot ypes and cardiometabolic risk, Fertil. Steril. 2012; 98(1):185–193.

Schlede E, Genschow E, Spielmann H, Stropp G, Kayser D. Oral acute toxic class method: a successful alternative to the oral LD50 test. Regul Toxicol Pharmacol. 2005;42(1):15–23.

D. Damayanthi, K.V.S.R.G. Prasad. Evaluation of Antidiabetic and Antioxidant activity of n-Cinnamoyl Metformin Analogues.Res. J. Pharmacology & Pharmacodynamics.2017; 9(2): 81-87.

Revathi. R, Julius. A. Effect of Insulin Resistance in Obese Polycystic Ovarian Disease. Research J. Pharm. and Tech. 2017; 10(7): 2160- 2162.

Beracah S. Mawlieh, C. S. Shastry, Sharad Chand. Evaluation of Anti-diabetic Activity of two marketed Herbal Formulations. Research J. Pharm. and Tech 2020;13(2):664-668.

Swati B. Pokale, Ghanshayam Jadhav. Piper longum (Linn.) restores ovarian function in Letrozole induced PCOS in Rats: Comparison with Metformin and Clomiphene citrate. Research Journal of Pharmacy and Technology. 2021; 14(10):5190-5196.

Gozif MN, Fadel YA, Mansour Abdulnabi H. Mehdi, Madhukar MF. Effects of Antioxidants (Micronutrients) with Metformin in type 2 Diabetic patients. Research Journal of Pharmacy and Technology. 2021; 14(4):1923-1927.

Revathi. R, Julius. A. A Biological Effect of Sex Hormone Binding Globulin and Testosterone in Polycystic Ovary Syndrome (PCOS) Obese Women. Research J. Pharm. and Tech. 2017; 10(7): 2143- 2145.

Wang F, Yu B, Yang W, Liu J, Lu J, Xia X. Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. J Ovarian Res. 2012;5(1):1–7.

Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian J Biol. 2002; 62(4A):609–614.

L. Manneras, S. Cajander, A. Holmäng, Z. Seleskovic, T. Lystig, M. Lönn et. Al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome, Endocrinology.2007; 148(8): 3781–3791.

Y. Feng, J. Johansson, R. Shao, L. Mannerås, J. Fernandez-Rodriguez, H. Billig, et.al Hypothalamic neuroendocrine functions in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture, PLoS One.2009; 4(8): e6638

Sornalakshmi V, Tresina SP, Paulpriya K, Packia LM, Mohan VR. Oral glucose tolerance test (OGTT) in normal control and glucose induced hyperglycemic rats with Hedyotis leschenaultiana DC. Group. 2016;8(1):1–9.

Nallathambi A, Bhargavan R. Regulation of estrous cycle by Cynodon dactylon in letrozole induced polycystic ovarian syndrome in Wistars albino rats. Anat Cell Biol. 2019;52(4):511–517.

Antunes LC, Elkfury JL, Jornada MN, Foletto KC, Bertoluci MC. Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats. Arch Endocrinol Metab. 2016; 60(2):138–142.

Ren D, Hu Y, Luo Y, Yang X. Selenium-containing polysaccharides from Ziyang green tea ameliorate high-fructose diet induced insulin resistance and hepatic oxidative stress in mice. Food Funct. 2015;6(10):3342–3350.

Safeeq Ahamed, M. Sumitra, V. Chitra. Prevalance and role of Melatonin on PCOS in its treatment using Herbal Drugs. Research Journal of Pharmacy and Technology. 2021; 14(9):5029- 5030.

Sally K, Marwan A, Abdul HN. Effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on lipid profile in vitamin D deficient/insufficient polycystic ovary syndrome patients: A Randomized, Placebo-Controlled Clinical Trial. Research J. Pharm. and Tech. 2019; 12(5):2327-2332.

Published

30-03-2022
Statistics
Abstract Display: 548
PDF Downloads: 470
Dimension Badge

How to Cite

“Effect of Nutraceutical Formulation Ovajal on DHT and Fructose-Induced Polycystic Ovary Syndrome in a Rodent Model”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 14, no. 2, Mar. 2022, pp. 256-61, https://doi.org/10.25004/IJPSDR.2022.140216.

Issue

Section

Research Article

How to Cite

“Effect of Nutraceutical Formulation Ovajal on DHT and Fructose-Induced Polycystic Ovary Syndrome in a Rodent Model”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 14, no. 2, Mar. 2022, pp. 256-61, https://doi.org/10.25004/IJPSDR.2022.140216.

Similar Articles

1-10 of 377

You may also start an advanced similarity search for this article.